These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 23492556)

  • 1. Cyclophilin D as a potential target for antioxidants in neurodegeneration: the X-ALD case.
    López-Erauskin J; Ferrer I; Galea E; Pujol A
    Biol Chem; 2013 May; 394(5):621-9. PubMed ID: 23492556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative stress underlying axonal degeneration in adrenoleukodystrophy: a paradigm for multifactorial neurodegenerative diseases?
    Galea E; Launay N; Portero-Otin M; Ruiz M; Pamplona R; Aubourg P; Ferrer I; Pujol A
    Biochim Biophys Acta; 2012 Sep; 1822(9):1475-88. PubMed ID: 22353463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative stress modulates mitochondrial failure and cyclophilin D function in X-linked adrenoleukodystrophy.
    López-Erauskin J; Galino J; Bianchi P; Fourcade S; Andreu AL; Ferrer I; Muñoz-Pinedo C; Pujol A
    Brain; 2012 Dec; 135(Pt 12):3584-98. PubMed ID: 23250880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antioxidants halt axonal degeneration in a mouse model of X-adrenoleukodystrophy.
    López-Erauskin J; Fourcade S; Galino J; Ruiz M; Schlüter A; Naudi A; Jove M; Portero-Otin M; Pamplona R; Ferrer I; Pujol A
    Ann Neurol; 2011 Jul; 70(1):84-92. PubMed ID: 21786300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of Lorenzo's oil on oxidative stress in X-linked adrenoleukodystrophy.
    Deon M; Wajner M; Sirtori LR; Fitarelli D; Coelho DM; Sitta A; Barschak AG; Ferreira GC; Haeser A; Giugliani R; Vargas CR
    J Neurol Sci; 2006 Sep; 247(2):157-64. PubMed ID: 16750542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early oxidative damage underlying neurodegeneration in X-adrenoleukodystrophy.
    Fourcade S; López-Erauskin J; Galino J; Duval C; Naudi A; Jove M; Kemp S; Villarroya F; Ferrer I; Pamplona R; Portero-Otin M; Pujol A
    Hum Mol Genet; 2008 Jun; 17(12):1762-73. PubMed ID: 18344354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of pharmacological induction of fatty acid beta-oxidation in X-linked adrenoleukodystrophy.
    McGuinness MC; Zhang HP; Smith KD
    Mol Genet Metab; 2001; 74(1-2):256-63. PubMed ID: 11592822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative stress is induced in female carriers of X-linked adrenoleukodystrophy.
    Deon M; Sitta A; Barschak AG; Coelho DM; Terroso T; Schmitt GO; Wanderley HY; Jardim LB; Giugliani R; Wajner M; Vargas CR
    J Neurol Sci; 2008 Mar; 266(1-2):79-83. PubMed ID: 17915255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valproic acid induces antioxidant effects in X-linked adrenoleukodystrophy.
    Fourcade S; Ruiz M; Guilera C; Hahnen E; Brichta L; Naudi A; Portero-Otín M; Dacremont G; Cartier N; Wanders R; Kemp S; Mandel JL; Wirth B; Pamplona R; Aubourg P; Pujol A
    Hum Mol Genet; 2010 May; 19(10):2005-14. PubMed ID: 20179078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant regulation of the GSK-3β/NRF2 axis unveils a novel therapy for adrenoleukodystrophy.
    Ranea-Robles P; Launay N; Ruiz M; Calingasan NY; Dumont M; Naudí A; Portero-Otín M; Pamplona R; Ferrer I; Beal MF; Fourcade S; Pujol A
    EMBO Mol Med; 2018 Aug; 10(8):. PubMed ID: 29997171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial dysfunction and oxidative damage cooperatively fuel axonal degeneration in X-linked adrenoleukodystrophy.
    Fourcade S; López-Erauskin J; Ruiz M; Ferrer I; Pujol A
    Biochimie; 2014 Mar; 98():143-9. PubMed ID: 24076127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pioglitazone halts axonal degeneration in a mouse model of X-linked adrenoleukodystrophy.
    Morató L; Galino J; Ruiz M; Calingasan NY; Starkov AA; Dumont M; Naudí A; Martínez JJ; Aubourg P; Portero-Otín M; Pamplona R; Galea E; Beal MF; Ferrer I; Fourcade S; Pujol A
    Brain; 2013 Aug; 136(Pt 8):2432-43. PubMed ID: 23794606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel acyl-CoA synthetase in adrenoleukodystrophy target tissues.
    Moriya-Sato A; Hida A; Inagawa-Ogashiwa M; Wada MR; Sugiyama K; Shimizu J; Yabuki T; Seyama Y; Hashimoto N
    Biochem Biophys Res Commun; 2000 Dec; 279(1):62-8. PubMed ID: 11112418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elongation of very long-chain fatty acids is enhanced in X-linked adrenoleukodystrophy.
    Kemp S; Valianpour F; Denis S; Ofman R; Sanders RJ; Mooyer P; Barth PG; Wanders RJ
    Mol Genet Metab; 2005 Feb; 84(2):144-51. PubMed ID: 15670720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Therapeutic Targets and Drug Candidates for Modifying Disease Progression in Adrenoleukodystrophy.
    Pujol A
    Endocr Dev; 2016; 30():147-60. PubMed ID: 26684655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tauroursodeoxycholic bile acid arrests axonal degeneration by inhibiting the unfolded protein response in X-linked adrenoleukodystrophy.
    Launay N; Ruiz M; Grau L; Ortega FJ; Ilieva EV; Martínez JJ; Galea E; Ferrer I; Knecht E; Pujol A; Fourcade S
    Acta Neuropathol; 2017 Feb; 133(2):283-301. PubMed ID: 28004277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The peroxisomal fatty acid transporter ABCD1/PMP-4 is required in the C. elegans hypodermis for axonal maintenance: A worm model for adrenoleukodystrophy.
    Coppa A; Guha S; Fourcade S; Parameswaran J; Ruiz M; Moser AB; Schlüter A; Murphy MP; Lizcano JM; Miranda-Vizuete A; Dalfó E; Pujol A
    Free Radic Biol Med; 2020 May; 152():797-809. PubMed ID: 32017990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative damage compromises energy metabolism in the axonal degeneration mouse model of X-adrenoleukodystrophy.
    Galino J; Ruiz M; Fourcade S; Schlüter A; López-Erauskin J; Guilera C; Jove M; Naudi A; García-Arumí E; Andreu AL; Starkov AA; Pamplona R; Ferrer I; Portero-Otin M; Pujol A
    Antioxid Redox Signal; 2011 Oct; 15(8):2095-107. PubMed ID: 21453200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of sirtuin 1 as therapy for the peroxisomal disease adrenoleukodystrophy.
    Morató L; Ruiz M; Boada J; Calingasan NY; Galino J; Guilera C; Jové M; Naudí A; Ferrer I; Pamplona R; Serrano M; Portero-Otín M; Beal MF; Fourcade S; Pujol A
    Cell Death Differ; 2015 Nov; 22(11):1742-53. PubMed ID: 25822341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antioxidant protection: A promising therapeutic intervention in neurodegenerative disease.
    Ghosh N; Ghosh R; Mandal SC
    Free Radic Res; 2011 Aug; 45(8):888-905. PubMed ID: 21615270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.